Subject
Cardiology and Cardiovascular Medicine
Reference11 articles.
1. Vericiguat in patients with heart failure and reduced ejection fraction;Armstrong;N Engl J Med,2020
2. N-terminal pro-B-type natriuretic peptide and clinical outcomes: vericiguat heart failure with reduced ejection fraction study;Ezekowitz;J Am Coll Cardiol HF,2020
3. Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction the SOCRATES-REDUCED randomized trial;Gheorghiade;JAMA,2015
4. A multicenter, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral soluble guanylate cyclase stimulator: the VICTORIA trial;Armstrong;J Am Coll Cardiol HF,2018
5. Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial;Pieske;Eur J Heart Fail,2019
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献